Pat Mcfarland
About Pat Mcfarland
Pat McFarland is the Associate Director of Regional Watershed Operations at Bristol-Myers Squibb in New Jersey, overseeing environmental compliance and sustainability initiatives.
Current Role at Bristol-Myers Squibb
Pat McFarland currently serves as Associate Director, Regional Watershed Operations at Bristol-Myers Squibb. Based in New Jersey, United States, McFarland oversees regional watershed operations, ensuring compliance with environmental regulations. In this role, McFarland plays a significant part in the company's environmental sustainability initiatives.
Previous Positions at Bristol-Myers Squibb
Before assuming the current role, Pat McFarland held the position of Assistant Director at Bristol-Myers Squibb. McFarland's tenure with the company began in January 2006, reflecting a long-term commitment to the organization. This extensive tenure has allowed McFarland to accumulate significant expertise in the management of watershed operations at a regional level.
Experience at Celgene
Pat McFarland also has professional experience working with Celgene, another notable entity in the biopharmaceutical industry. This tenure contributed to McFarland's broad expertise in biopharmaceutical research and development, particularly in managing Risk Evaluation and Mitigation Strategies (REMS) programs, ensuring patient safety, and compliance with FDA regulations.
Expertise in Regulatory Compliance and Patient Safety
With an extensive background in the pharmaceutical industry, Pat McFarland is well-versed in the regulatory requirements of this sector. McFarland has shown a commitment to improving patient access to medications, advocating for health equity, and supporting underserved patients. Engaging in initiatives to help patients understand their insurance coverage and out-of-pocket costs is a key component of McFarland's contributions.
Support for Generic Drugs and Educational Outreach
Pat McFarland supports the development and use of generic drugs, recognizing their importance in expanding patient access to essential medications. Additionally, McFarland is involved in educational outreach and communication efforts related to medication safety, striving to enhance patient knowledge and ensure a better understanding of pharmaceutical products.